Unlock stock picks and a broker-level newsfeed that powers Wall Street.
In Vitro Diagnostics Business Outlook 2022: Twice-Monthly Publication Dedicated to IVD
Company Logo
Company Logo

Dublin, May 04, 2022 (GLOBE NEWSWIRE) -- The "In Vitro Diagnostics Business Outlook" newsletter has been added to ResearchAndMarkets.com's offering.

The twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook will offer the following:

  • Market Sizing and Forecasting of IVD Market Segments in Every Issue

  • Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care-Updates on the Important Test Categories You Need to Know About

  • Industry Watch - Developments with COVID-19 and Other Testing

  • M&A, Distribution, Partnerships Tracked and Charted

  • New Product Introductions and Company Announcements

  • Company Profiling and Quarterly Results Summaries

  • Regional Market Coverage

For more information about this newsletter visit https://www.researchandmarkets.com/r/39it8x

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900